Qventus | AI Transformation Index
Qventus is an AI-native healthcare operations platform with genuine domain intelligence advantages — proprietary multi-system workflow data and behavioral ...

Overview
Qventus sells AI-powered software platforms to health systems that automate hospital operational workflows — surgical scheduling, perioperative coordination, and inpatient capacity management — integrating with EHRs and generating revenue through SaaS subscriptions tied to measurable operational outcomes.
Executive Summary
Qventus is an AI-native healthcare operations platform with genuine domain intelligence advantages — proprietary multi-system workflow data and behavioral science integration — but faces a structural durability challenge as EHR incumbents (particularly Epic) build competing AI-native operational tools that threaten to absorb its middleware position. From an Opportunity perspective, the self-sufficiency discount applies: Qventus is already building advanced AI and does not need outside catalysis to capture AI value, limiting the PE-relevant transformation upside. The strategic question for THL is not whether AI matters to Qventus — it is the product — but whether Qventus can establish defensible system-of-record positioning in specific workflow domains before the EHR layer commoditizes operational AI, and whether the $1.2B valuation appropriately prices that execution risk.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
52.5
Ciridae AI Score
Durability Rationale
Qventus's structural vulnerability is its position as a middleware layer above the EHR system-of-record in a market where EHR incumbents — Epic foremost — are aggressively moving into AI-native operational intelligence. The profit pool migration risk is the dominant durability concern: as the EHR becomes the AI operations platform, Qventus's distinct value proposition narrows. Meaningful but not decisive structural protections exist in the form of long hospital IT sales cycles, regulatory complexity, and workflow embedding that creates switching friction — but these slow the threat rather than neutralize it. The company's durability ultimately depends on whether it can achieve system-of-record status in its specific workflow domains before EHR incumbents commoditize the function.
Opportunity Rationale
As an AI-native company, Qventus has already captured much of the obvious step-change in AI applicability — the self-sufficiency discount applies strongly here. The residual opportunity is real but incremental: moving from AI-assisted recommendations to fully agentic workflow execution, expanding the use-case surface area (coding automation, care gap identification, outpatient settings), and amplifying proprietary multi-system operational data through increasingly powerful foundation models. The most compelling Opportunity angle is domain intelligence amplification — Qventus has accumulated behavioral and operational pattern data across health systems that creates a compounding advantage as AI models improve. This is not the massive unrealized cognitive labor compression story of a 10,000-person manual workforce, but a product differentiation and data flywheel story.
Key Risks
EHR incumbents — particularly Epic, which has already launched AI-native scheduling and capacity tools — could move faster than expected to commoditize operational optimization as a native platform feature, collapsing Qventus's distinct value proposition and pricing power before it achieves sufficient scale and embedding to defend its position.
Qventus's AI advantage may prove less proprietary than the data flywheel thesis suggests: if general-purpose foundation models improve rapidly enough to match its domain-specific optimization without proprietary training data, the differentiation collapses and the Opportunity from domain intelligence amplification is overstated.
Company Overview
| Headquarters | Mountain View, California, United States |
| Products / Services | AI Operational Assistants platform, Surgical Growth solution, Inpatient Capacity solution, Perioperative Care Coordination, Malnutrition Care Automation, other AI-powered healthcare automation solutions |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
$50 million growth capital round led by Thomas H. Lee Partners, LP. February 28, 2022 |
Executives
| Name | Background |
|---|---|
Mudit Garg CEO | Founder and CEO at Qventus, Inc for over 13 years. Previously founded Hive Inc. and worked as a Consultant at McKinsey & Company for 2 years. Also served as a Financial Technology Engineering Analyst at Citadel Investment Group. |
Mike Levin VP, Finance | Vice President of Finance at Qventus. Educated at The Wharton School. Limited public data on previous roles beyond Qventus. |
Pat Saxman Chief Revenue Officer | Chief Growth Officer at Medely for over 3 years. Former Chief Growth Officer at Qventus. Studied at West Point, and serves on multiple boards. |
Matt Heim Chief Business Development Officer | Chief of Sales at Qventus for over 7 years. Former VP of Sales at Medtronic, Area VP at Intuitive Surgical, Director at Mindray North America. |
Jeff Mounzer Chief Product Officer | Chief Product Officer at Qventus for over 2 years. Previously Senior Product Manager at Medallia, adjunct lecturer at Stanford, PhD student at Stanford. |
Abhinav Mittal Chief Technology Officer | Engineering executive at Qventus. Limited detailed public info on previous roles. |
David Atashroo Chief Clinical Officer | Former Physician at UCSF Health for 9 years. Oversees clinical strategy at Qventus. |
Jason Cohen Chief Medical Officer, Inpatient | Former Chief Medical Officer at North Valley Hospital, hospitalist at Marcus Daly Memorial Hospital, MD from University of Chicago. |
Jeff Evans Chief Commercial Officer | Joined Qventus in March 2025. Previously CCO at PartsSource Inc., CEO at CAE Healthcare, VP at CAE Healthcare. |
Thomas H. Lee Partners